C terminal half fragment (50 kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine.
about
Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.Subunit vaccine efficacy against Botulinum neurotoxin subtypes.Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.Subunit vaccine against the seven serotypes of botulismThe strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison.Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry.Intradermal injection of Botulinum toxin type A alleviates infraorbital nerve constriction-induced thermal hyperalgesia in an operant assay.
P2860
Q34920929-434161E7-B053-4046-88FB-B97F1FF40DB7Q35139316-C7FADF39-CA18-4E1C-9650-8A6D04D8D412Q35532054-5BEB9EDF-AB8E-45A1-A048-B4F4D1B48630Q36143517-51BFD254-9702-4ACB-AA79-E141AD00DF73Q36483548-A5E33D74-D145-49B5-A56F-6913C64F09ADQ37289989-4D7ED802-DB43-41AC-820A-C6C31B903262Q38847565-A26F650B-581C-4B8C-8E5A-078B6784E8F4Q39261922-DF71BB16-8B91-40A5-A1AC-2F635F5854B5
P2860
C terminal half fragment (50 kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
C terminal half fragment (50 k ...... used as an effective vaccine.
@en
C terminal half fragment
@nl
type
label
C terminal half fragment (50 k ...... used as an effective vaccine.
@en
C terminal half fragment
@nl
prefLabel
C terminal half fragment (50 k ...... used as an effective vaccine.
@en
C terminal half fragment
@nl
P2093
P2860
P1476
C terminal half fragment (50 k ...... used as an effective vaccine.
@en
P2093
Hideyuki Arimitsu
Hyun-Jung Hwang
Jae-Chul Lee
Keiji Oguma
Takao Tsuji
Tohru Ohyama
Tomofusa Tsuchiya
Toshihiro Watanabe
Yoshihiko Sakaguchi
Yumiko Yamamoto
P2860
P304
P356
10.1111/J.1348-0421.2007.TB03919.X
P577
2007-01-01T00:00:00Z